158 related articles for article (PubMed ID: 20947684)
1. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
Yin B; Yang-Iott KS; Chao LH; Bassing CH
Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
[TBL] [Abstract][Full Text] [Related]
2. Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
Bassing CH; Ranganath S; Murphy M; Savic V; Gleason M; Alt FW
Blood; 2008 Feb; 111(4):2163-9. PubMed ID: 17855626
[TBL] [Abstract][Full Text] [Related]
3. Redundant and nonredundant functions of ATM and H2AX in αβ T-lineage lymphocytes.
Yin B; Lee BS; Yang-Iott KS; Sleckman BP; Bassing CH
J Immunol; 2012 Aug; 189(3):1372-9. PubMed ID: 22730535
[TBL] [Abstract][Full Text] [Related]
4. Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.
DeMicco A; Yang-Iott K; Bassing CH
Cell Cycle; 2013 Oct; 12(20):3307-16. PubMed ID: 24036547
[TBL] [Abstract][Full Text] [Related]
5. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.
Bassing CH; Suh H; Ferguson DO; Chua KF; Manis J; Eckersdorff M; Gleason M; Bronson R; Lee C; Alt FW
Cell; 2003 Aug; 114(3):359-70. PubMed ID: 12914700
[TBL] [Abstract][Full Text] [Related]
6. PARP1 and DNA-PKcs synergize to suppress p53 mutation and telomere fusions during T-lineage lymphomagenesis.
Rybanska I; Ishaq O; Chou J; Prakash M; Bakhsheshian J; Huso DL; Franco S
Oncogene; 2013 Apr; 32(14):1761-71. PubMed ID: 22614020
[TBL] [Abstract][Full Text] [Related]
7. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
8. The RAG2 C terminus suppresses genomic instability and lymphomagenesis.
Deriano L; Chaumeil J; Coussens M; Multani A; Chou Y; Alekseyenko AV; Chang S; Skok JA; Roth DB
Nature; 2011 Mar; 471(7336):119-23. PubMed ID: 21368836
[TBL] [Abstract][Full Text] [Related]
9. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
10. Development of thymic lymphomas in mice disrupted of Brca2 allele in the thymus.
Park PG; Lee H
Exp Mol Med; 2008 Jun; 40(3):339-44. PubMed ID: 18587272
[TBL] [Abstract][Full Text] [Related]
11. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
[TBL] [Abstract][Full Text] [Related]
13. Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.
Gostissa M; Bianco JM; Malkin DJ; Kutok JL; Rodig SJ; Morse HC; Bassing CH; Alt FW
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):2934-9. PubMed ID: 23382223
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice.
Liu X; Karnell JL; Yin B; Zhang R; Zhang J; Li P; Choi Y; Maltzman JS; Pear WS; Bassing CH; Turka LA
J Clin Invest; 2010 Jul; 120(7):2497-507. PubMed ID: 20516645
[TBL] [Abstract][Full Text] [Related]
15. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
[TBL] [Abstract][Full Text] [Related]
16. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
17. Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice.
Strzadala L; Miazek A; Matuszyk J; Kisielow P
Int Immunol; 1997 Jan; 9(1):127-38. PubMed ID: 9043954
[TBL] [Abstract][Full Text] [Related]
18. TCR v(beta) repertoire restriction and lack of CDR3 conservation implicate TCR-superantigen interactions in promoting the clonal evolution of murine thymic lymphomas.
Gomez G; Clarkin KZ; Kraig E; Infante AJ; Richie ER
Int Immunol; 2000 Mar; 12(3):263-70. PubMed ID: 10700461
[TBL] [Abstract][Full Text] [Related]
19. Process for immune defect and chromosomal translocation during early thymocyte development lacking ATM.
Isoda T; Takagi M; Piao J; Nakagama S; Sato M; Masuda K; Ikawa T; Azuma M; Morio T; Kawamoto H; Mizutani S
Blood; 2012 Jul; 120(4):789-99. PubMed ID: 22709691
[TBL] [Abstract][Full Text] [Related]
20. 53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice.
Ward IM; Difilippantonio S; Minn K; Mueller MD; Molina JR; Yu X; Frisk CS; Ried T; Nussenzweig A; Chen J
Mol Cell Biol; 2005 Nov; 25(22):10079-86. PubMed ID: 16260621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
